0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Immune Checkpoint Proteins > OX40 > OX0-R5254

Rabbit OX40 / TNFRSF4 / CD134 Protein, Fc Tag

  • Synonym
    TNFRSF4,OX40,CD134,OX40L receptor,ACT35,TXGP1L
  • Source
    Rabbit OX40, Fc Tag (OX0-R5254) is expressed from human 293 cells (HEK293). It contains AA Ala 19 - Gln 208 (Accession # O02764).
    Predicted N-terminus: Ala 19
  • Molecular Characterization
    Online(Ala 19 - Gln 208) O02764

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 47.3 kDa. As a result of different glycosylation, the protein migrates as 48 kDa and 68 kDa under reducing (R) condition, and 120-135 kDa under non-reducing (NR) condition (SDS-PAGE).

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >85% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5. Normally trehalose is added as protectant before lyophilization.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
Rabbit OX40, Fc Tag (Cat. No. OX0-R5254) SDS-PAGE gel

Rabbit OX40, Fc Tag on SDS-PAGE under reducing (R) and non-reducing (NR) conditions. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.

Comments (0)

Order Details

Price(USD) : $315.00

Price(USD) : $1850.00

Promotion & Exhibitions

  • PEGS Boston 2019
  • PepTalk 2019

Drug Development Status

  • Number of Launched Drugs:0 Details
  • Number of Drugs in Clinical Trials:14 Details
  • Latest Research Phase:Phase ?

Datasheet & Documentation

Contact Us

+1  800-810-0816 (US)
+86 400-682-2521 (AP)

Questions & Comments

This web search service is supported by Google Inc.

totop